Crossmark

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s12885-021-08183-y

Published Online: 2021-05-10

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Żok, Jolanta

Bieńkowski, Michał

Radecka, Barbara

Korniluk, Jan

Adamowicz, Krzysztof

Duchnowska, Renata
License Information

Text and Data Mining valid from 2021-05-10

Version of Record valid from 2021-05-10
More Information

Article History

Received: 14 June 2020

Accepted: 13 April 2021

First Online: 10 May 2021

Declarations

:

: Bioethics Committee, Medical Chamber in Opole (Agreement No. 245/2017).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below